🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,867 results for “De” Clear

  1. ORENCIA 125 mg solution for injection in pre-filled syringe, ORENCIA 125 mg solution for injection in pre-filled syringe, RoActemra 162 mg solution for injection in pre-filled syringe., ORENCIA 125 mg solution for injection in pre-filled syringe, ORENCIA 125 mg solution for injection in pre-filled syringe, RoActemra 162 mg solution for injection in pre-filled syringe., ORENCIA 125 mg solution for injection in pre-filled syringe, ORENCIA 125 mg solution for injection in pre-filled syringe, ORENCIA 125 mg sol

    The George Institute

    Adults patients suffering from rheumatoid arthritis and in adequate response to one or two targeted treatments.

    approved small molecule active

    1 trial

  2. Olutasidenib

    RIGEL PHARMACEUTICALS INC

    AML (Acute Myeloid Leukemia)

    approved small molecule active

    1 trial

  3. Omega 3-Atorvastatin

    United Therapeutics Europe Ltd

    Dyslipidemias

    approved small molecule active

    1 trial

  4. Oral Zonisamide Therapy

    Affiliated Hospital of Nantong University

    Epilepsies, Partial

    approved small molecule active

    1 trial

  5. Oxycodone Hydrochloride

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Analgesia, Patient-Controlled

    approved small molecule active

    1 trial

  6. PALEXIA Retard 50 mg tabletten met verlengde afgifte

    Disc Medicine

    chronic postoperative pain

    approved small molecule active

    1 trial

  7. PDD regimen: doxorubicin hydrochloride iposome, bortizomib and dexamethasone

    The First People's Hospital of Lianyungang

    Multiple Myeloma

    approved small molecule active

    1 trial

  8. PEG-rhG-CSF

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cervical Cancer

    approved small molecule active

    1 trial

  9. PEG-somatropin

    Changchun GeneScience Pharmaceutical Co.,

    Growth Hormone Deficiency

    approved mab active

    1 trial

  10. PEG-somatropin

    The First People's Hospital of Lianyungang

    Growth Hormone Deficiency

    approved mab active

    1 trial

  11. PEG-somatropin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Growth Hormone Deficiency

    approved mab active

    2 trials

  12. PROPESS 10 mg, système de diffusion vaginal, PROSTINE E2 2 mg/3 g, gel vaginal, ANGUSTA 25 microgrammes, comprime, OXYTOCINE PANPHARMA 5 UI/1 ml, solution injectable

    Tour Hekla

    Labor Induction of women with an unfavorable Cervix after 24 hours of cervical ripening

    approved small molecule active

    1 trial

  13. Pandemic influenza A/H1N1 vaccine

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  14. Pantoprazole Teva 40 mg maagsapresistente tabletten, Mycophenolate mofetil Sandoz 500 mg Film-coated Tablets, Mycophenolate Mofetil Accord 500 mg plėvele dengtos tabletės, CellCept 500 mg film-coated tablets

    Disc Medicine

    Post Transplantation Patients

    approved small molecule active

    1 trial

  15. Parecoxib

    The First People's Hospital of Lianyungang

    Postoperative Pain Management, Pain Threshold, Shoulder Pain, Laparoscopies

    approved small molecule completed

    1 trial

  16. Parecoxib

    The First People's Hospital of Lianyungang

    Emergence Delirium

    approved small molecule active

    1 trial

  17. Pegylated Interferon

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  18. Pentocur 1 g pulver till injektionsvätska, lösning

    The George Institute

    Major depressive disorder

    approved small molecule active

    1 trial

  19. Pharmacotherapy for opioid use disorder

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    approved small molecule completed

    1 trial

  20. Pimavanserin

    Acadia Pharmaceuticals B.V.

    Neurodegenerative Diseases

    approved small molecule active

    1 trial

  21. Pioglitazone 15mg

    United Therapeutics Europe Ltd

    High Altitude

    approved small molecule completed

    1 trial

  22. Placebo

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastroesophageal Reflux Disease

    approved other active

    1 trial

  23. Placebo

    Takeda

    Post-Traumatic Stress Disorder

    approved small molecule completed

    1 trial

  24. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources